MT Newswires23h agoneutral
Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC SaysVertex Pharmaceuticals (VRTX) reported a solid Q2 and raised its outlook, highlighting the strength
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
490last 24h
2474last 7d
479● bullish (7d)
251● bearish (7d)
197publishers